Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
RSC Adv ; 13(31): 21283-21295, 2023 Jul 12.
Article in English | MEDLINE | ID: mdl-37456552

ABSTRACT

This study shows a simplistic, efficient procedure to synthesize TiO2-MoO3-BMIMBr nanocomposites. Powder X-ray diffraction, scanning electron microscopy, energy-dispersive X-ray spectroscopy, and X-ray photoelectron spectroscopy have all been used to completely analyse the materials. The detection of acetaminophen (AC) has been examined at a modified glassy carbon electrode with TiO2-MoO3-BMIMBr nanocomposites. Moreover, the electrochemical behavior of the nanocomposite modified electrode has been studied by cyclic voltammetry (CV), differential pulse voltammetry (DPV), chronoamperometry and electrochemical impedance spectroscopy (EIS). The linear response of AC was observed in the range 8.26-124.03 nM. The sensitivity and detection limits (S/N = 3) were found to be 1.16 µA L mol-1 cm-2 and 11.54 nM by CV and 24 µA L mol-1 cm-2 and 8.16 nM by DPV respectively.

2.
Eur J Med Chem ; 59: 304-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23262035

ABSTRACT

A novel series of substituted (E)-3-(Benzo [d]thiazol-2-ylamino)phenylprop-2-en-1-onewere synthesized starting from 2-aminobenzothiazole and 1-aryl-3,3-bis- (methylsulfanyl)-2-propen-1-onesin the presence of a catalytic amount of sodium hydride in THF. The synthesised compounds' structures were confirmed by IR, Mass spectrometry, (1)H NMR, (13)C NMR and HRMS spectral data. These compounds were evaluated for their antidiabetic activity, and most of the derivatives of (E)-3-(Benzo [d]thiazol-2-ylamino)phenylprop-2-en-1-one displayed significant antidiabetic activity.


Subject(s)
Hypoglycemic Agents , Amylases/antagonists & inhibitors , Animals , Benzothiazoles/chemical synthesis , Benzothiazoles/chemistry , Benzothiazoles/pharmacology , Crystallography, X-Ray , Enzyme Activation/drug effects , Glucosidases/antagonists & inhibitors , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , Inhibitory Concentration 50 , Magnetic Resonance Spectroscopy , Mice , Molecular Structure , Propiophenones/chemical synthesis , Propiophenones/chemistry , Propiophenones/pharmacology , Swine
3.
Bioorg Med Chem Lett ; 22(23): 7011-4, 2012 Dec 01.
Article in English | MEDLINE | ID: mdl-23102653

ABSTRACT

A series of (2-phenyl-4H-benzopyrimodo[2,1-b][1,3]thiazol-4-yliden-4-yliden)acetonitrile derivatives have been prepared by ring transformation reaction of 4-(methylthio)-2-oxo-6-aryl-2H-pyrane-3-carbonitriles. The yield of ring transformation product is moderate to good. Furthermore the glycosidase inhibitory activities were tested by using α-amylase and α-glucosidase pancreatic, intestinal and liver enzymes, responsible for hyperglycemia in type II diabetes. The results revealed that all compounds exhibit significant glycosidase inhibitory activity.


Subject(s)
Acetonitriles/chemistry , Acetonitriles/pharmacology , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Glycoside Hydrolase Inhibitors , Hypoglycemic Agents/chemical synthesis , Acetonitriles/chemical synthesis , Acetonitriles/metabolism , Amylases/antagonists & inhibitors , Amylases/metabolism , Animals , Enzyme Activation/drug effects , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/metabolism , Intestines/enzymology , Liver/enzymology , Mice , Pancreas/enzymology , Protein Binding , Swine , alpha-Glucosidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...